Showing 1 - 12 results of 12 for search 'V. D. Pasechnikov', query time: 0.02s
Refine Results
-
1
-
2
-
3
-
4
Clinical course of ascitic syndrome and acute kidney injury in the setting of nonselective beta‑blockers or endoscopic variceal ligation for primary prevention of bleeding in cirrh... by R. V. Korobka, S. V. Gautier, V. D. Pasechnikov, E. S. Pak, A. M. Shapovalov, Yu. V. Khoronko, D. V. Pasechnikov, I. A. Porshennikov
Published 2024-04-01Get full text
Article -
5
-
6
The use of endoscopic band ligation in the primary prevention of bleeding in patients with ascites listed in the liver transplantation waiting list by V. L. Korobka, V. D. Pasechnikov, R. V. Korobka, E. S. Pak, A. M. Shapovalov, D. V. Pasechnikov, N. G. Sapronova, Y. V. Khoronko
Published 2023-06-01Get full text
Article -
7
Transjugular intrahepatic portosystemic shunt or a combination of nonselective beta blockers and endoscopic variceal ligation for prophylaxis of bleeding in waitlisted cirrhotic... by R. V. Korobka, S. V. Gautier, Yu. S. Khoronko, V. D. Pasechnikov, N. G. Sapronova, I. A. Porshennikov, M. V. Malevanny, E. S. Pak, D. V. Pasechnikov
Published 2024-07-01Get full text
Article -
8
Azygoportal disconnection or a combination of non-selective beta-blockers and endoscopic variceal ligation to prevent recurrent bleeding in patients with cirrhosis awaiting trans... by R. V. Korobka, S. V. Gautier, Yu. V. Khoronko, V. D. Pasechnikov, A. M. Shapovalov, M. V. Malevanny, E. S. Pak, D. V. Pasechnikov, E. V. Tadiyeva
Published 2024-07-01Get full text
Article -
9
Recommendations for the prevention and treatment of hepatitis B and C infection in patients on the waiting list for liver transplantation and in liver transplant recipients by M. Sh. Khubutiya, S. E. Voskanyan, V. E. Syutkin, V. P. Chulanov, M. S. Novruzbekov, V. D. Pasechnikov, V. L. Korobka, O. O. Rummo, E. N. Bessonova, S. F. Bagnenko, D. I. Abdulganiyeva
Published 2020-09-01Get full text
Article -
10
Delisting of liver transplant candidates following recompensation of chronic liver diseases – patient characteristics and predictors of delisting: a prospective study by V. L. Korobka, V. D. Pasechnikov, E. S. Pak, M. Y. Kostrykin, A. V. Tkachev, N. I. Balin, R. E. Gromyko, R. V. Korobka, A. M. Shapovalov, A. M. Babieva, A. B. Mikutin, V. S. Agabekyan
Published 2020-02-01Get full text
Article -
11
Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study by D. T. Abrurakhmanov, V. G. Morozov, I. G. Nikitin, P. O. Bogomolov, N. I. Geyvandova, Ye. N. Bessonova, I. G. Bakulin, V. A. Isakov, K. V. Zhdanov, M. V. Mayevskaya, Ye. A. Nurmukhametova, E. Z. Burnevich, Ye. V. Chesnokov, V. D. Pasechnikov, A. Hill, I. Lonjon-Domanec, S. N. Kizhlo
Published 2014-07-01Get full text
Article -
12
Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER st... by M. V. Mayevskaya, V. T. Ivashkin, O. O. Znoyko, Ye. A. Klimova, D. T. Abdurakhmanov, I. G. Bakulin, P. O. Bogomolov, E. Z. Burnevich, M. Yu. Galushko, N. I. Geyvandova, K. V. Zhdanov, Ye. V. Esaulenko, S. N. Kizhlo, D. Yu. Konstantinov, N. I. Mironova, V. G. Morozov, Ye. A. Strebkova, I. G. Nikitin, M. F. Osipenko, V. D. Pasechnikov, O. I. Sagalova, I. M. Khayertynova, V. P. Chulanov, A. A. Yakovlev, I. A. Vasyutin, Ye. P. Tarkhova, E. N. Krasavina, M. Yu. Samsonov
Published 2018-08-01Get full text
Article